Printer Friendly

Improved rifamycin B production by Nocardia mediterranei MTCC 14 under solid-state fermentation through process optimization.

1. Introduction

Rifamycin B is powerful, less toxic, and easily biodegradable antibacterial ansamycin antibiotic [1] and is produced by strain of Nocardia mediterranei. It bear distinct critical antibacterial activities [2], including tuberculosis, leprosy, and AIDS-related mycobacterial infections [3]. So rifamycin B hasbecome one of the most effective antibacterial ansamycin antibiotics.

Processes that can be used for rifamycin B production include submerged fermentation (SmF) and solid-state fermentation (SSF). The solid-state fermentation is particularly beneficial for antibiotics production by filamentous actinomyces, since it simulates the natural habitat of these production strains [4,5]. Another benefit of SSF is that agroindustrial residues (sesame oil cake, soybean cake, coconut oil cake, mustard oil cake, palm kernel cake, groundnut oil cake, cottonseed cake, canola oil cake, olive oil cake, rapeseed cake, etc.) can be used as the solid substrate, acting as sources of both carbon and energy. However, certain operational conditions of SSF, such as barrier in controlling. The moisture content of the substrate and avoiding heat buildup have bounded its industrial application. The influence of variety of nutrients, pH, and substrate moisture content on the kinetics of growth and rifamycin B formation is crucial for SSF process scale-up [6]. The strains that have been considered for the production of rifamycin B under SSF include Amycolatopsis sp. RSP 3 [6].

Oil cakes have chief nutritional value and are possibly valuable substrates for use in biotechnological SSF processes for the manufacture of chief value products such as antibiotics [7,8] and enzymes [9,10]. The development of new sunflower varieties has enabled edible oils to be obtained from rapeseed, which is now the world's second largest source of edible oil. The by-product of oil extraction, sunflower oil cake, not only is a rich source of nitrogen, carbon, and minerals but also is ample and economical [11]. However, despite the ability of Nocardia strains and their certified applications in antibiotics production, to the best of our apprehension there have been no studies concerning the characterization of these actinomyces for the production of rifamycin B using sunflower oil cake as solid substrate in SSF.

Plackett-Burman design and response surface methodology (RSM) are competent statistical techniques for optimizing complex processes because it allows additional, capable, and easier adaptation and explication of experiments compared to conventional methods [12, 13]. In addition, it is less arduous and time consuming than other conventional methods to optimize a process. It is extensively used for optimization of the process conditions of the fermentation medium [14-16].

In this paper, we describe the optimization of appropriate fermentation medium conditions for rifamycin B production, with the help of both conventional and statistical optimization techniques.

2. Materials and Methods

2.1. Microorganism, Preparation of Inoculum. Nocardia mediterranei MTCC14 was obtained from the Microbial Type Culture Collection and Gene Bank (MTCC), Chandigarh, India, and was used in this study for rifamycin B production. The strain was maintained on agar-slant medium (pH 8.0) consisting of (g/L) dextrose 20, glycerol 20, yeast extract 5, beef extract 3, casein hydrolysate 3, peptone 2.5, malt extract 1, and agar 20 and stored at 48C. These slants were subcultured on regular intervals. The spores were harvested and suspended in sterile distilled water containing 0.01% (v/v) Tween 80 to obtain approximately 2.0 x [10.sup.6] spores/mL.

2.2. Raw Materials. Sunflower oil cake was collected fromRaja Fat and Feeds Private Limited, Rajpura, Punjab, India. The collected sunflower oil cake was first dried and mechanically milled with a lab mill (Ultra Centrifugal Mill) and sieved through standard mesh sieves (200-500 [micro]m) using an electronic sieve shaker to obtain the powder of 200-500 [micro]m particle sizes.

23. Optimization for Rifamycin B Production by One-Variable at-a-Time Approach. SSF was carried out in a 250 mL Erlenmeyer conical flask containing 4 g solid substrate (sunflower oil cake). In the present paper, the requirement of medium components including various carbon (5% [w/w], glucose, maltose, galactose, ribose, and xylose) and nitrogen sources (7% [w/w], peanut meal, beef extract, soybean meal, ammonium sulphate, and ammonium chloride), barbital (1%, 2%, 3%, 4%, and 5%), pH (7.0, 7.5, 8.0, 8.5, and 9.0), and moisture content (40%, 45%, 50%, 55%, and 60%) were optimized.

The sunflower oil cake was supplemented with (in mg) soybean meal 250, calcium carbonate 75, potassium nitrate 100, barbital 20, and magnesium sulphate 1 with predetermined quantity of water. The contents of the flasks were mixed thoroughly and autoclaved at 121[degrees]C for 15 min at 1 kgf/[cm.sup.2]. After cooling the flasks to room temperature, the flasks were inoculated with 2.0 x [10.sup.6] spores/mL under sterile conditions [6]. The pH adjustment of solid medium was achieved by adjusting the pH of moisturizing medium before being added to the solid material. The contents of the flasks were fully mixed and incubated at 28 [+ or -] 0.5[degrees]C for predetermined time period and used for extraction and estimation of rifamycin B.

2.4. Extraction of Antibiotics. Enzyme extraction was carried out by mixing fermented mass with distilled water for 1 h on an orbital shaker at 200 rpm. Contents of the flasks were filtered through muslin cloth and the filtrate was centrifuged at 2070 xg for 10 min. The supernatant obtained was used for rifamycin B estimation.

2.5. Estimation of Rifamycin B. Rifamycin B was estimated according to the method of Pasqualucci et al. [17]. Reaction mixture contained 0.1 mL of suitably diluted antibiotics + 5 mL of 0.2 M acetate buffer (pH 4.63) and the absorbance was read at 425 nm using UV-Visible spectrophotometer (SHIMADZU UV-1800), against 0.1 mL of antibiotic solution diluted to 5 mL with acetate buffer, pH 4.63, containing 0.1% NaNO2. Rifamycin B production under SSF was expressed as g/kgds dry fermented mass. Each sample was tested in duplicate.

2.6. Experimental Design. Single factor experiment was used to select the best carbon and nitrogen sources, barbital, pH, and moisture levels.

2.7. Response Surface Methodology. Response surface methodology was applied in two stages, first to identify the significant processes parameters for production of rifamycin B using Plackett-Burman design test and later the significant processes parameters which resulted from Plackett-Burman design were optimized by using a central composite design. The experimental design and statistical analysis of the data were accomplished by using Stat-Ease Design Expert statistical software package (trial version7).

2.8. Plackett-Burman Design. Plackett-Burman design test was applied to describe the significant variables responsible for production of rifamycin B from Nocardia mediterranei MTCC 14. This design test assumes that there are no interactions between the different production parameters and is based on the first-order model:

Y = [[beta].sub.0] + [summatipn][[beta].sub.i][x.sub.i], (1)

where Y is the estimated direct function, [[beta].sub.0] is the scaling constant, [[beta].sub.i] is the regression coefficients, and [x.sub.i] is the variables. The effect of eleven variables with coded notation (glucose (X1), maltose (X2), ribose (X3), galactose (XA), beef extract (X5), peanut meal (X6), ammonium chloride (X7), ammonium sulphate (X8), barbital (X9), pH (X10), and moisture content (X11)) on the production of rifamycin B was tested at two experimental levels, high level denoted by (+) and a low level denoted by (-), as listed in Table 1. Eleven variables were screened by conducting 12 experiments and the experimental design is given in Table 2. All experiments were conducted in duplicate and the average value of extracted rifamycin B was used for statistical analysis.

The variables which were significant at 5% level (P < 0.05) from the regression analysis as given in Table 3 were reasoned to have major effect on production of rifamycin B and were further optimized by central composite design.

2.9. Central Composite Design. A central composite design was applied to determine the optimum level of four significant production parameters screened from Placket-Burman design test. As shown in Table 4 the effect of four processes parameters (galactose (X4), ribose (X3), glucose (X1), and pH (X10)) on the production of rifamycin B was calculated at five experimental levels, -[alpha], -1, 0, +1, and +[alpha], where [alpha] = [2.sup.n/4]; here n is the number of variables and 0 corresponds to the central point. The experimental levels for these variables were preferred from our preliminary work, which indicated that an optimum could be built within the level of processes parameters calculated. The levels of factors used for experimental design are given in Table 4. The actual level of each factor was calculated by the following equation [18]:

Coded value = actual level - (high level + low level)/2/(high level - low level)/2. (2)

The experimental design scheme is given in Table 5. Rifamycin B yield was analyzed by using a second-order polynomial equation and the data were fitted into the equation by multiple regression procedure. The model equation for analysis is given below:


where Y is the predicted response, [X.sub.1], ..., [X.sub.4] are the levels of the factors, [[beta].sub.1], ..., [[beta].sub.4] are linear coefficients, [[beta].sub.11], ..., [[beta].sub.44] are quadratic coefficients, and [[beta].sub.12], ..., [[beta].sub.34] are the interactive coefficients with [[beta].sub.0] is a scaling constant. Analysis of variance (ANOVA), regression analysis was done. The surface and contour plots were drawn by using Stat-Ease Design Expert statistical software package (trial version7).

2.10. Data Analysis. The quality of the fit of the polynomial model equation was uttered by the coefficient of determination [R.sup.2], and its statistical significance was checkered by F-test. The significance level was given as values of Prob > F less than 0.1. A differential calculation was then engaged for predicting the optimum point.

3. Results and Discussion

3.1. Screening of Carbon and Nitrogen Sources, Barbital, pH, and Moisture Content for Production of Rifamycin B. In the introductory step of optimization, the preferred nutrients and physical parameters were applied to sunflower oil cake separately. The complementary nutrients and physical parameters really advance concentration of rifamycin B of Nocardia mediterranei MTCC 14.

The effect of supplementation with various carbon and nitrogen sources and barbital and application of physical parameters such as pH and moisture content of the medium on rifamycin B production by Nocardia mediterranei MTCC 14 is shown in Figures 1-5. Carbon and nitrogen sources, in the basal medium, were at a level of 5% (w/w) and 7% (w/w), barbital of 1%, 2%, 3%, 4%, and 5%, pH of 7.0,7.5,8.0, 8.5, and 9.0, and moisture content of 40%, 45%, 50%, 55%, and 60%.

The effects of supplementation with carbon sources were studied at a level of 5% w/w and were generally found to have a good effect on the production of rifamycin B (Figure 1). Glucose, maltose, ribose, and galactose supplementation showed the highest production of rifamycin B at 5.78, 4.89, 4.35, and 3.87 g/kgds dry sunflower oil cake at the day eight of incubation. These data further indicate that though the sunflower oil cake material provides carbon source required for Nocardia mediterranei MTCC 14 growth and subsequent rifamycin B production, it was observed to be insufficient medium for optimum production. Such improved metabolite production values were also reported for Amycolatopsis sp. RSP 3 with supplementation of external carbon sources under SSF [6].

Rifamycin B production in different microbial strains is reported to be supported by the presence of various organic nitrogen sources such as beef extract [6], soybean meal [19], peanut meal [20], ammonium sulphate [6], and ammonium chloride [6] during solid-state fermentation. Hence, the effect of different nitrogen sources on rifamycin B production by Nocardia mediterranei MTCC 14 was studied at optimized SSF environment. The effect of the supplementation of nitrogen sources was studied by adding various nitrogen sources at a concentration of 7% w/w. Results indicated that they almost completely stimulated the production of rifamycin B at the day eight of incubation. Soybean meal did not affect rifamycin B yield (Figure 2) compared to control (CL). Almost all the nitrogen sources tested increased the rifamycin B production at the day eight of incubation.

Rifamycin B production is affected by the appearance of barbital in the fermentation medium [21, 22]. It is reported that barbital negatively regulates the electron transport system and increases the accessibility of oxygen to other cellular activities which in turn improves rifamycin production [23]. Supplementation with various concentrations of barbital gave a significantly higher rifamycin B yield at day 8 of incubation (Figure 3).

The influence of wide ranges of pH from 7 to 9 [6] on the production of rifamycin B from corn husk has been reported. Results revealed (Figure 4) that pH 8.5 was optimum for the maximum production of rifamycin B from sun flower oil cake in solid-state conditions. Krishna et al. [24] also reported similar observations. Wide range of initial pH of the medium during the upstream bioprocess makes the end product either acidic or alkaline, which tends to have varied applications [25]. However, the influence of pH on the production of rifamycin B from sun flower oil cake was significant when compared to submerged conditions.

Different amounts of water were added to dry sunflower oil cake, and the effect on rifamycin B production is shown in Figure 5, where the maximum production of rifamycin B was 8.65 g/kgds dry sunflower oil cake at 55% moisture content. Increasing the moisture content beyond 60% caused a decrease in the production of rifamycin B, which may be due to poor gas exchange as a result of water batting the pore spaces between the solid medium particles. Similarly, Mahalaxmi et al. [6] used 57% moisture content for the production of rifamycin B from corn husk.

Based on the above experiments, glucose, maltose, ribose, galactose, beef extract, peanut meal, ammonium chloride, ammonium sulphate, barbital, pH, and moisture content were selected for statistical optimization.

3.2. Screening of Production Parameters Using Plackett-Burman Design Test. A total of eleven variables were analyzed with regard to their effects on rifamycin B yield using a Plackett-Burman design (Table 1). The design matrix selected for screening of significant variables for rifamycin B production and the corresponding responses are shown in Table 2. The adequacy of the model was calculated, and the variables evidencing statistically significant effects were screened via regression analysis (Table 3). Among the eleven production parameters (glucose, maltose, ribose, galactose, beef extract, peanut meal, ammonium chloride, ammonium sulphate, barbital, pH, and moisture content) studied, four parameters (galactose, ribose, glucose, and pH) were found to have significant influence on rifamycin B production as evidenced by their P values (< 0.05, significant at 5% level) obtained from regression analysis. We used the Pareto chart in order to calculate the amplitude and worth of an independent variable and its interaction with the dependent variable (Figure 6). The chart displays the actual value of the effects and draws a reference line on the chart. The length of each bar in the chart indicates the standardized effect of that factor on the response. Any effect that extends past this reference line is possibly significant for that certain process [26]. The fact that the bars for maltose, beef extract, peanut meal, ammonium chloride, ammonium sulphate, barbital, and moisture content remained inward the reference line as shown in Figure 6 denotes that these terms contributed to the least prediction of the rifamycin B production. The coefficient of determination ([R.sup.2]) of the model was found to be 0.9996 which indicates that the model can explain up to 99.96% variation of the data. Rifamycin B yield obtained from Plackett-Burman design experiments showed wide variation (0.2-1.9%), which indicated that further optimization is necessary to get a maximum response.

3.3. Effects of Galactose, Ribose, Glucose, and pH on Rifamycin B Production. Response surface methodology using central composite design was practical to optimize the levels of significant production parameters resulting from Plackett-Burman design experiments. Thirty experiments were carried out from the design and the experimental values are given in Table 5. All the experiments were carried out in duplicate; the mean value of rifamycin B yield was taken for statistical analysis. By applying multiple regression analysis on the experimental data, the following second-order polynomial equation was developed:


The effects of galactose (X4), ribose (X3), glucose (X1), and pH (X10) on rifamycin B production are reported in Table 7. Response surfaces for rifamycin B yield are shown in Figures 7-12, which give the surface and contour plots for the effect of galactose, ribose, glucose, and pH on the rifamycin B yield. Regression analysis of the experimental data (Table 7) showed that galactose and ribose had significant positive linear effects on rifamycin B yield, while glucose and pH had negative linear effect on rifamycin B yield. This was clear from the low P value obtained from the regression analysis. Among the four processes parameters, galactose was found to have the highest impact on rifamycin B yield as given by the highest linear coefficient (1.66) followed by ribose (0.23), while glucose (-0.40) and pH (-1.38) have negative linear effect. These production parameters also showed significant positive quadratic effects on rifamycin B yield indicating that rifamycin B production increased as the level of these factors increased and decreased as the level of these processes parameters decreased below certain values. Table also indicates that the interaction between ribose and pH and between galactose and ribose has significant effect on rifamycin B production and all other interactive variables are insignificant. Hence, only the term indicating interaction between ribose and pH and between galactose and ribose was included in the model regression equation (4).

Figures 7-12 show the surface and contour plots of rifamycin B produced for each pair of production parameters by keeping the other two production parameters constant at its central level. The effect of galactose and ribose on the production of rifamycin B is shown in Figure 7. The maximum rifamycin B (8.34 g/kgds) was obtained at galactose 8.5% w/w and ribose 3.25% w/w. Further increase in concentration of galactose and ribose leads to increase in production of rifamycin B. Figure 8 indicates that the maximum rifamycin B was produced (5.57 g/kgds) when galactose and glucose were 8% w/w and 9% w/w; further increase in the concentration of galactose leads to increase in production of rifamycin B and further decrease in the concentration of glucose leads to increase in production of rifamycin B. The surface and contour plot of Figure 9 indicates that the maximum rifamycin B (4.80 g/kgds) production occurred at the galactose of 9% w/w and pH of 7. The production of rifamycin B increases with increase in concentration of galactose up to 9% w/w and decrease in pH up to 7 and further increase in the concentration of galactose and further decrease in pH lead to increase in the production of rifamycin B. Figure 10 indicates that the maximum rifamycin B is produced at the concentrations of ribose above 4% w/w and below 3% w/w and glucose above 9% w/w and below 8% w/w. Maximum rifamycin B was produced when concentration of ribose was above 4% w/w and below 3% w/w and pH was 7 (Figure 11). Further decrease in pH leads to acceleration of rifamycin B production. Figure 12 surface and contour plot shows that maximum rifamycin B was produced at concentration of glucose of 9% w/w and pH was 7.

3.4. Statistical Analysis. Analysis of variance for the rifamycin B produced from Nocardia mediterranei MTCC 14 obtained from this design was given in Table 6. ANOVA gives the value of the model and can account for whether this model adequately fits the variation observed in rifamycin B produced with the designed production level. If the F-test for the model is significant at the 5% level (P < 0.05), then the model is fit and can satisfactorily explain the variation ascertained. If the F-test for lack of fit is significant (P < 0.05), then a more complex model is essential to adapt the data. The high F-value and nonsignificant lack of fit indicated that the quadratic model was highly significant, as reported in [27, 28]. The P value for lack of fit (0.0006) reveals that the experimental data obtained fit well with the model and explains the effect of galactose, ribose, glucose, and pH on rifamycin B produced from the Nocardia mediterranei MTCC 14. The nearer the value of [R.sup.2] (coefficient of determination) to 1, the more correct the correlation between the observed and predicted values. Here the value of [R.sup.2] (0.9547) indicates that the model can explain up to 95.47% variation of rifamycin B yield obtained. A coefficient of variance (CV) value of 26.34 reveals the high precision and reliability of the experimental data. Adequate precision greater than 4.0 is desirable, and the ratio was found to be 12.510 (> 4.0), which indicates that the derived model is significant for the rifamycin B production. The predicted residual sum of squares (PRESS) value was 122.79, which showed how the derived model fits with each point in the given design [29].

3.5. Adequacy of the Model. Model adequacy scrutiny was used, in order to find whether the derived model would give sufficient approximation values to the actual values [30]. Raw residuals are elements of variation for the given data, which cannot be explained by the model, representing the deviations between the experimental and predicted values. The predicted values from the model were quite close to the experimental values, and the data of all predicted and experimental response values lie in a straight line (Figure 13) indicating that the derived model was able to well predict the correlation between the process variables on the response.

3.6. Validation of the Model. The experimental data were fitted into the model (4) and the optimum values were found to be as follows: galactose 8% w/w, ribose 3% w/w, glucose 9% w/w, and pH 7.0. Optimum levels of production parameters for production of rifamycin B from Nocardia mediterranei MTCC14 was 9.87 g/kgds, which is very close to the predicted value of 10.35 g/kgds.

4. Conclusion

Response surface methodology was well used to optimize the production parameters for production of rifamycin B from Nocardia mediterranei MTCC 14. To optimize various processes parameters for production of rifamycin B from Nocardia mediterranei MTCC 14 eleven processes parameters (glucose, maltose, ribose, galactose, beef extract, peanut meal, ammonium chloride, ammonium sulphate, barbital, pH, and moisture content) were tried by using Plackett-Burman design test and the four processes parameters galactose, ribose, glucose, and pH showed significant effects on production of rifamycin B. The actuality of interactions between the processes parameters was calculated and the interaction between ribose and pH and between galactose and ribose showed significant effects on production of rifamycin B. The production parameters were optimized by applying central composite design and the parameters for the highest production of rifamycin B from Nocardia mediterranei MTCC 14 were found to be galactose (8% w/w), ribose (3% w/w), glucose (9% w/w), and pH (7.0). The maximum rifamycin B yield from Nocardia mediterranei MTCC 14 was 9.87 g/kgds dry sunflower oil cake. The second-order polynomial model developed was found to be acceptable in describing the experimental data. This is the first report of the optimization of production of rifamycin B from Nocardia mediterranei MTCC 14 using response surface methodology.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


The authors gratefully acknowledge the technical support provided by the Department of Biochemistry, Kuvempu University, Shimoga.


[1] W. Oppolzer and V. Prelog, "The constitution and configuration of rifamycins B, O, S and SV," Helvetica Chimica Acta, vol. 56, no. 7, pp. 2287-2314, 1973.

[2] P. Sensi, A. M. Greco, and R. Ballotta, "Rifomycin. I. Isolation and properties of rifomycin B and rifomycin complex," Antibiotics Annual, vol. 7, pp. 262-270, 1959.

[3] H. G. Floss and T.-W. Yu, "Rifamycin--mode of action, resistance, and biosynthesis," Chemical Reviews, vol. 105, no. 2, pp. 621-632, 2005.

[4] U. H. Olker and J. Lenz, "Solid-state fermentationare there any biotechnological advantages?" Current Opinion in Microbiology, vol. 8, no. 3, pp. 301-306, 2005.

[5] J. Barrios-Gonzalez, "Solid-state fermentation: physiology of solid medium, its molecular basis and applications," Process Biochemistry, vol. 47, no. 2, pp. 175-185, 2012.

[6] Y. Mahalaxmi, T. Sathish, C. Subba Rao, and R. S. Prakasham, "Corn husk as a novel substrate for the production of rifamycin B by isolated Amycolatopsis sp. RSP 3 under SSF," Process Biochemistry, vol. 45, no. 1, pp. 47-53, 2010.

[7] K. P. Kota and P. Sridhar, "Solid state cultivation of Streptomyces clavuligerus for cephamycin C production," Process Biochemistry, vol. 34, no. 4, pp. 325-328, 1999.

[8] A. Sircar, P. Sridhar, and P. K. Das, "Optimization of solid state medium for the production of clavulanic acid by Streptomyces clavuligerus," Process Biochemistry, vol. 33, no. 3, pp. 283-289, 1998.

[9] H.-S. Joo, C. G. Kumar, G.-C. Park, S. R. Paik, and C.-S. Chang, "Oxidant and SDS-stable alkaline protease from Bacillus clausiiI-52: production and some properties," Journal of Applied Microbiology, vol. 95, no. 2, pp. 267-272, 2003.

[10] H.-S. Joo and C.-S. Chang, "Production of protease from a new alkalophilic Bacillus sp. I-312 grown on soybean meal: optimization and some properties," Process Biochemistry, vol. 40, no. 3-4, pp. 1263-1270, 2005.

[11] A. Lomascolo, E. Uzan-Boukhris, J.-C. Sigoillot, and F. Fine, "Rapeseed and sunflower meal: a review on biotechnology status and challenges," Applied Microbiology and Biotechnology, vol. 95, no. 5, pp. 1105-1114, 2012.

[12] Y. Zhang, Z. Liu, Y. Li, and R. Chi, "Optimization of ionic liquid-based microwave-assisted extraction of isoflavones from Radix puerariae by response surface methodology," Separation and Purification Technology, vol. 129, pp. 71-79, 2014.

[13] M. Taghvaei, S. M. Jafari, E. Assadpoor, S. Nowrouzieh, and O. Alishah, "Optimization of microwave-assisted extraction of cottonseed oil and evaluation of its oxidative stability and physicochemical properties," Food Chemistry, vol. 160, no. 1, pp. 90-97, 2014.

[14] A. Abalos, F. Maximo, M. A. Manresa, and J. Bastida, "Utilization of response surface methodology to optimize the culture media for the production of rhamnolipids by Pseudomonas aeruginosa AT10," Journal of Chemical Technology & Biotechnology, vol. 77, no. 7, pp. 777-784, 2002.

[15] F. Zhao, M. Mandlaa, J. Hao et al., "Optimization of culture medium for anaerobic production of rhamnolipid by recombinant Pseudomonas stutzeri Rhl for microbial enhanced oil recovery," Letters in Applied Microbiology, vol. 59, no. 2, pp. 231-237, 2014.

[16] C. Li, J. Bai, Z. Cai, and F. Ouyang, "Optimization of a cultural medium for bacteriocin production by Lactococcus lactis using response surface methodology," Journal of Biotechnology, vol. 93, no. 1, pp. 27-34, 2002.

[17] C. R. Pasqualucci, A. Vigevani, P. Radaelli, and G. G. Gallo, "Improved differential spectrophotometric determination of rifamycins," Journal of Pharmaceutical Sciences, vol. 59, no. 5, pp. 685-687, 1970.

[18] A. I. Varnalis, J. G. Brennan, D. B. MacDougall, and S. G. Gilmour, "Optimisation of high temperature puffing of potato cubes using response surface methodology," Journal of Food Engineering, vol. 61, no. 2, pp. 153-163, 2004.

[19] Z.-H. Jin, J.-P Lin, and P-L. Cen, "Scale-up of rifamycin B fermentation with Amycolatoposis mediterranei," Journal of Zhejiang University: Science, vol. 5, no. 12, pp. 1590-1596, 2004.

[20] G. Venkateswarlu, P S. M. Krishna, A. Pandey, and L. V. Rao, "Evaluation of Amycolatopsis mediterranei VA18 for production of rifamycin-B," Process Biochemistry, vol. 36, no. 4, pp. 305-309, 2000.

[21] Y. Mahalaxmi, C. Subba Rao, G. S. Laxmi, T Satish, P Sudhakar, and R. S. Prakasham, "Rifamycin B production pattern in Nocardia RSP-3 strain and influence of barbital on antibiotic production," Current Trends in Biotechnology and Pharmacy, vol. 2, no. 1, pp. 208-216, 2008.

[22] A. Mejia, G. Viniegra-Gonzalez, and J. Barrios-Gonzalez, "Biochemical mechanism of the effect of barbital on rifamycin B biosynthesis by Amycolatopsis mediterranei (M18 strain)," Journal of Bioscience and Bioengineering, vol. 95, no. 3, pp. 288-292, 2003.

[23] A. Mejia, J. Barrios-Gonzalez, and G. Viniegra-Gonzalez, "Overproduction of rifamycin B by Amycolatopsis mediterranei and its relationship with the toxic effect of barbital on growth," Journal of Antibiotics, vol. 51, no. 1, pp. 58-63, 1998.

[24] P S. M. Krishna, G. Venkateswarlu, and L. V. Rao, "Studies on fermentative production of rifamycin using Amycolatopsis mediterranei," World Journal of Microbiology and Biotechnology, vol. 14, no. 5, pp. 689-691, 1998.

[25] O. M. El-Tayeb, A. A. Salama, M. M. M. Hussein, and H. F. El-Sedawy, "Optimization of industrial production of rifamycin B by Amycolatopsis mediterranei. I. The role of colony morphology and nitrogen sources in productivity," African Journal of Biotechnology, vol. 3, no. 5, pp. 266-272, 2004.

[26] M. Shanmugaprakash, J. Kirthika, J. Ragupathy, K. Nilanee, and A. Manickam, "Statistical based media optimization and production of naringinase using Aspergillus brasiliensis 1344," International Journal of Biological Macromolecules, vol. 64, pp. 443-452, 2014.

[27] R. M. Banik and D. K. Pandey, "Optimizing conditions for oleanolic acid extraction from Lantana camara roots using response surface methodology," Industrial Crops and Products, vol. 27, no. 3, pp. 241-248, 2008.

[28] S. Ibanoglu and E. Ibanoglu, "Modelling of natural fermentation in cowpeas using response surface methodology," Journal of Food Engineering, vol. 48, no. 3, pp. 277-228, 2001.

[29] R. Minjares-Fuentes, A. Femenia, M. C. Garau, J. A. Meza-Velazquez, S. Simal, and C. Rosselloa, "Ultrasound-assisted extraction of pectins from grape pomace using citric acid: a response surface methodology approach," Carbohydrate Polymers, vol. 106, no. 1, pp. 179-189, 2014.

[30] M. B. Abdul Rahman, N. I. Jarmi, N. Chaibakhsh, and M. Basri, "Modeling and optimization of lipase-catalyzed production of succinic acid ester using central composite design analysis," Journal of Industrial Microbiology & Biotechnology, vol. 38, no. 1, pp. 229-234, 2011.

Basavaraj M. Vastrad, (1) Shivayogeshwar E. Neelagund, (2) Sudhir R. Iiger, (3) Ajeet M. Godbole, (3) and Venkatrao Kulkarni (4)

(1) Department of Pharmaceutical Biotechnology, S.E. TS College of Pharmacy, Dharwad, Karnataka 580002, India

(2) Department of PG Studies in Biochemistry, Kuvempu University, Jnana Sahyadri campus, Shankaraghatta, Shimoga 577 451, India

(3) Department of Pharmaceutics, S.E.T's College of Pharmacy, Dharwad, Karnataka 580002, India

(4) Department of Pharmacology, S.E.T's College of Pharmacy, Dharwad, Karnataka 580002, India

Correspondence should be addressed to Basavaraj M. Vastrad;

Received 4 July 2014; Accepted 10 September 2014; Published 9 October 2014

Academic Editor: Ziad Fajloun

TABLE 1: Level of the production parameters for production
of rifamycin B from Nocardia mediterranei MTCC14 by using
Plackett-Burman design test.

Processes       Medium composition         High         Low
parameters        and conditions         level (+)   level (-)

X1                Glucose % (w/w)            7           5
X2                Maltose % (w/w)            7           5
X3                Ribose % (w/w)             7           5
X4               Galactose % (w/w)           7           5
X5             Beef extract % (w/w)          9           7
X6              Peanut meal % (w/w)          9           7
X7           Ammonium chloride % (w/w)       9           7
X8           Ammonium sulphate % (w/w)       9           7
X9               Barbital % (w/w)            3           2
X10                     pH                   9           7
X11             Moisture content %          60          50

TABLE 2: Yield of rifamycin B from Nocardia mediterranei
MTCC 14 using the different levels of production variables
of Plackett-Burman design test.

Std.        X1   X2   X3   X4   X5   X6   X7
run order

2           -1   1    1    -1   1    1    1
9           1    1    1    -1   -1   -1   1
1           1    1    -1   1    1    1    -1
5           -1   -1   1    -1   1    1    -1
10          -1   1    1    1    -1   -1   -1
11          1    -1   1    1    1    -1   -1
6           -1   -1   -1   1    -1   1    1
12          -1   -1   -1   -1   -1   -1   -1
8           1    1    -1   -1   -1   1    -1
7           1    -1   -1   -1   1    -1   1
4           -1   1    -1   1    1    -1   1
3           1    -1   1    1    -1   1    1

Std.        X8   X9   X10   X11   Yield
run order                         g/kgds

2           -1   -1   -1     1     5.21
9           -1   1     1    -1     6.38
1           -1   -1    1    -1     7.84
5           1    1     1    -1     2.89
10          1    -1    1     1     6.32
11          -1   1    -1     1     8.35
6           -1   1     1     1     7.32
12          -1   -1   -1    -1     6.97
8           1    1    -1     1     8.31
7           1    -1    1     1     7.47
4           1    1    -1    -1     9.43
3           1    -1   -1    -1     8.48

Eleven variables, X1, glucose, X2, maltose, X3, ribose,
X4, galactose, X5, beef extract, X6, peanut meal, X7,
ammonium chloride, X8, ammonium sulphate, X9, barbital,
X10, pH, and X11, moisture content, were screened by
conducting 12 experiments.

TABLE 3: ANOVA of Plackett-Burman design test data for
the significant production parameters.

Source               SS     df    MS     F value   P value

Model               33.52   11   3.35    264.42    0.0478
Glucose             6.29    1    6.29    496.49    0.0286
Maltose             0.34    1    0.34     26.56    0.1220
Ribose              7.86    1    7.86    619.88    0.0256
Galactose           9.21    1    9.21    726.23    0.0236
Beefextract         0.56    1    0.56     44.10    0.0951
Peanut meal         1.98    1    1.98    155.93    0.0509
Ammonium chloride   1.09    1    1.09     85.68    0.0685
Ammonium sulphate   0.057   1    0.057    4.53     0.2796
Barbital            0.013   1    0.013    3.78     0.9522
pH                  6.06    1    6.06    478.38    0.0291
Moisture content    0.082   1    0.082    6.44     0.2389

[R.sup.2] = 0.9996

Galactose, ribose, glucose, and pH were significant
(P < 0.05). SS: sum of square, MS: mean of square,
df: degree of freedom, P value: Fisher's value, and
P: probability.

Table 4: Production variables and their coded and actual values
used for optimization of rifamycin B production from mediterranei
MTCC 14 by using central composite design.

Production                          Coded level
                    Symbol    -2    -1     0      1     2

Galactose % (w/w)     X4     750    8.0   8.50   9.0   9.50
Ribose % (w/w)        X3     2.50   3.0   3.50   4.0   4.50
Glucose % (w/w)       X1     7.50   8.0   8.50   9.0   9.50
pH % (w/w)           X10     6.75   7.0   7.25   7.5   7.75

TABLE 5: Experimental design and results using central
composite design.

Std. run   Production parameters levels   Yield g/kgds
            X4     X3     X1    X10

7          8.00   4.00   9.00   7.00        0.89
30         8.50   3.50   8.50   7.25        0.32
11         8.00   4.00   8.00   7.50        7.27
15         8.00   4.00   9.00   7.50        1.53
18         9.50   3.50   8.50   7.25        9.34
2          9.00   3.00   8.00   7.00        9.42
29         8.50   3.50   8.50   7.25        0.53
28         8.50   3.50   8.50   7.25        0.89
27         8.50   3.50   8.50   7.25        0.43
26         8.50   3.50   8.50   7.25        0.75
21         8.50   3.50   750    7.25        0.86
8          9.00   4.00   9.00   7.00        6.76
9          8.00   3.00   8.00   7.50        2.37
20         8.50   4.50   8.50   7.25        9.56
13         8.00   3.00   9.00   7.50        0.34
14         9.00   3.00   9.00   7.50        1.54
4          9.00   4.00   8.00   7.00        9.78
6          9.00   3.00   9.00   7.00        8.65
1          8.00   3.00   8.00   7.00        9.34
12         9.00   4.00   8.00   7.50        9.34
16         9.00   4.00   9.00   7.50        9.64
22         8.50   3.50   9.50   7.25        1.76
25         8.50   3.50   8.50   7.25        0.32
23         8.50   3.50   8.50   6.75        8.24
24         8.50   3.50   8.50   7.75        3.86
3          8.00   4.00   8.00   7.00        2.34
19         8.50   2.50   8.50   7.25        9.42
10         9.00   3.00   8.00   7.50        0.74
5          8.00   3.00   9.00   7.00        9.87
17         750    3.50   8.50   7.25        0.34

X4: galactose, X3: ribose, X1: glucose, and X10: pH.

TABLE 6: ANOVA for the fitted quadratic polynomial model of
rifamycin B production from mediterranei MTCC14 by using
central composite design.

Source          SS     DF     MS       F     P value    Significance

Model         453.92   14   32.42    22.59   <0.0001     Significant
X4            66.40    1    66.40    46.27   <0.0001     Significant
X3             1.29    1     1.29    0.90    0.3584    Not significant
X1             3.82    1     3.82    2.66    0.1234    Not significant
X10           45.49    1    45.49    31.70   <0.0001     Significant
X4X3          39.25    1    39.25    27.35   0.0001      Significant
X4X1           2.25    1     2.25    1.57    0.2297    Not significant
X4X10          0.37    1     0.37    0.26    0.6209    Not significant
X3X1           4.45    1     4.45    3.10    0.0985    Not significant
X3X10         101.51   1    101.51   70.74   <0.0001     Significant
X1X10          0.24    1     0.24    0.17    0.6833    Not significant
X42           33.60    1    33.60    23.42   0.0002      Significant
X32           141.26   1    141.26   98.44   <0.0001     Significant
X12            1.38    1     1.38    0.96    0.3422    Not significant
X102          54.48    1    54.48    37.97   <0.0001     Significant
Residual      21.52    15    1.43
Lack of fit   21.25    10    2.12    38.55   0.0004    Not significant
Pure error     0.28    5    0.055
Cor. total    475.45   29

Std. dev.: 1.20, [R.sup.2]: 0.9547

Mean: 4.55, adjusted [R.sup.2]: 0.9125.

Coefficient of variation (CV) %: 26.34,
predicted [R.sup.2]: 0.7118.

Predicted residual sum of squares (PRESS): 122.79,
adequate precision: 12.510.

SS: sum of square, MS: mean of square,
and df: degree of freedom.

TABLE 7: Coefficients of the multivariate
process models for the rifamycin B production
from mediterranei MTCC.

Factor      Coefficient   Standard
            of estimate    error

Intercept      0.54         0.49
X4             1.66         0.24
X3             0.23         0.24
X1             -0.40        0.24
X10            -1.38        0.24
X4X3           1.57         0.30
X4X1           0.37         0.30
X4X10          -0.15        0.30
X3X1           -0.53        0.30
X3X10          2.52         0.30
X1X10          -0.12        0.30
X42            1.11         0.23
X32            2.27         0.23
X12            0.22         0.23
X102           1.41         0.23
COPYRIGHT 2014 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Vastrad, Basavaraj M.; Neelagund, Shivayogeshwar E.; Iiger, Sudhir R.; Godbole, Ajeet M.; Kulkarni,
Publication:Biochemistry Research International
Article Type:Report
Date:Jan 1, 2014
Previous Article:Production and partial purification of alpha amylase from Bacillus subtilis (MTCC 121) using solid state fermentation.
Next Article:Protective effect of theaflavin on erythrocytes subjected to in vitro oxidative stress.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters